Progyny, Inc. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
Progyny, Inc. (PGNY) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of -$3.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2026-08-07
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2026-06-30 was -$3.52M.
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2026-03-31 was -$3.38M.
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-12-31 was -$7.87M.
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-09-30 was -$2.10M.
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2025 was -$15.44M.
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2024 was -$9.59M.
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2023 was -$11.10M.
- Progyny, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2022 was -$7.33M.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.52M 10-Q · filed 2026-08-07 | -$6.90M 10-Q · filed 2026-08-07 | -$14.77M derived: sum of 3 quarters · filed 2026-08-07 | -$16.87M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$3.38M 10-Q · filed 2026-05-08 | -$11.25M derived: sum of 2 quarters · filed 2026-05-08 | -$13.35M derived: sum of 3 quarters · filed 2026-05-08 | -$15.78M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$7.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$9.97M derived: sum of 2 quarters · filed 2026-02-27 | -$12.40M derived: sum of 3 quarters · filed 2026-08-07 | -$15.44M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$2.10M 10-Q · filed 2025-11-07 | -$4.53M derived: sum of 2 quarters · filed 2026-08-07 | -$7.58M 10-Q · filed 2025-11-07 | -$9.11M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$2.43M 10-Q · filed 2026-08-07 | -$5.47M 10-Q · filed 2026-08-07 | -$7.01M derived: sum of 3 quarters · filed 2026-08-07 | -$8.57M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$3.04M 10-Q · filed 2026-05-08 | -$4.58M derived: sum of 2 quarters · filed 2026-05-08 | -$6.14M derived: sum of 3 quarters · filed 2026-05-08 | -$9.13M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$3.09M derived: sum of 2 quarters · filed 2026-02-27 | -$6.08M derived: sum of 3 quarters · filed 2026-02-27 | -$9.59M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$1.56M 10-Q · filed 2025-11-07 | -$4.55M derived: sum of 2 quarters · filed 2025-11-07 | -$8.05M 10-Q · filed 2025-11-07 | -$13.41M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$2.99M 10-Q · filed 2025-08-08 | -$6.49M 10-Q · filed 2025-08-08 | -$11.86M derived: sum of 3 quarters · filed 2026-02-27 | -$14.03M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$3.50M 10-Q · filed 2025-05-09 | -$8.86M derived: sum of 2 quarters · filed 2026-02-27 | -$11.04M derived: sum of 3 quarters · filed 2026-02-27 | -$13.19M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$7.54M derived: sum of 2 quarters · filed 2026-02-27 | -$9.69M derived: sum of 3 quarters · filed 2026-02-27 | -$11.10M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$2.17M 10-Q · filed 2024-11-12 | -$4.33M derived: sum of 2 quarters · filed 2024-11-12 | -$5.74M 10-Q · filed 2024-11-12 | -$8.91M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$2.15M 10-Q · filed 2024-08-07 | -$3.56M 10-Q · filed 2024-08-07 | -$6.74M derived: sum of 3 quarters · filed 2025-03-03 | -$7.72M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$1.42M 10-Q · filed 2024-05-10 | -$4.58M derived: sum of 2 quarters · filed 2025-03-03 | -$5.57M derived: sum of 3 quarters · filed 2025-03-03 | -$6.78M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$4.15M derived: sum of 2 quarters · filed 2025-03-03 | -$5.37M derived: sum of 3 quarters · filed 2025-03-03 | -$7.33M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$984.00K 10-Q · filed 2023-11-08 | -$2.20M derived: sum of 2 quarters · filed 2023-11-08 | -$4.16M 10-Q · filed 2023-11-08 | -$6.79M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$1.21M 10-Q · filed 2023-08-04 | -$3.17M 10-Q · filed 2023-08-04 | -$5.81M derived: sum of 3 quarters · filed 2024-02-29 | -$10.17M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$1.96M 10-Q · filed 2023-05-09 | -$4.60M derived: sum of 2 quarters · filed 2024-02-29 | -$8.96M derived: sum of 3 quarters · filed 2024-02-29 | -$14.07M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$7.00M derived: sum of 2 quarters · filed 2024-02-29 | -$12.11M derived: sum of 3 quarters · filed 2024-02-29 | -$14.59M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$4.36M 10-Q · filed 2022-11-04 | -$9.47M derived: sum of 2 quarters · filed 2022-11-04 | -$11.95M 10-Q · filed 2022-11-04 | -$14.11M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$5.11M 10-Q · filed 2022-08-05 | -$7.59M 10-Q · filed 2022-08-05 | -$9.75M derived: sum of 3 quarters · filed 2023-03-01 | -$10.37M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$2.48M 10-Q · filed 2022-05-06 | -$4.63M derived: sum of 2 quarters · filed 2023-03-01 | -$5.26M derived: sum of 3 quarters · filed 2023-03-01 | -$8.53M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.78M derived: sum of 2 quarters · filed 2023-03-01 | -$6.05M derived: sum of 3 quarters · filed 2023-03-01 | -$5.45M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$628.00K 10-Q · filed 2021-11-08 | -$3.89M derived: sum of 2 quarters · filed 2021-11-08 | -$3.29M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$3.26M 10-Q · filed 2021-08-06 | -$2.67M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $597.00K 10-Q · filed 2021-05-07 | |||
| 2019-09-30 | $4.98M 10-Q · filed 2020-11-06 | $5.01M 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |